Severity
Critical
FDA Drug recall · Reported December 27, 2023
Chemical Contamination; presence of benzene.
Insight Pharmaceuticals Corporation recalled TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (… - a critical-severity action.
TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (… was recalled by Insight Pharmaceuticals Corporation in December 27, 2023. Reason: Chemical Contamination; presence of benzene.. Check the official notice for the remedy. Verify recall #D-0151-2024 with the FDA Drug before acting.
The recall
Insight Pharmaceuticals Corporation issued this critical-severity FDA Drug recall-Chemical Contamination; presence of benzene..
Sourced from official FDA Drug enforcement records. Verify recall #D-0151-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0151-2024) was formally reported on December 27, 2023, with the manufacturer initiating the action on November 22, 2023. It is classified under Critical severity (Class I), with a current status of Completed. Insight Pharmaceuticals Corporation is listed as the recalling firm, operating out of Langhorne, PA. Federal records list the affected scope as 117,336 cans.
The documented reason for this recall is: Chemical Contamination; presence of benzene. Distribution data in the federal record shows the product reached: Nationwide and Puerto Rico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
117,336 cans
Related Recalls
6
5 from same agency
TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591, UPC 363736532611.
Chemical Contamination; presence of benzene.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Completed |
| Recall number | D-0151-2024 |
| Date reported | December 27, 2023 |
| Date initiated | November 22, 2023 |
| Recalling firm | Insight Pharmaceuticals Corporation |
| Firm location | Langhorne, PA |
| Affected scope | 117,336 cans |
| Distribution | Nationwide and Puerto Rico |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported December 27, 2023. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.